An Open-label, Single-arm, Multi-center, Phase IV Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX in Healthy Adults in Korea
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Varicella zoster virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Merck & Co; Merck Sharp & Dohme
- 01 Jan 2016 Results published in the Journal of Korean Medical Science
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.